GR 127935 and (+)-WAY 100135 do not affect TFMPP-induced inhibition of 5-HT synthesis in the midbrain and hippocampus of Wistar-Kyoto rats
- 1 September 1998
- journal article
- Published by Elsevier in Neuropharmacology
- Vol. 37 (9) , 1159-1167
- https://doi.org/10.1016/s0028-3908(98)00107-5
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- GR 127935 reduces basal locomotor activity and prevents RU 24969-, but not D -amphetamine-induced hyperlocomotion, in the Wistar-Kyoto Hyperactive (WKHA) ratPsychopharmacology, 1999
- Effects of Food Deprivation on Midbrain 5-HT 1A Autoreceptors in Lewis and SHR RatsNeuropharmacology, 1997
- Effects of 5-HT1A receptor antagonists on hippocampal 5-hydroxytryptamine levels: (S)-WAY100135, but not WAY100635, has partial agonist propertiesEuropean Journal of Pharmacology, 1996
- 5-HT2 receptor subtypes: A family re-united?Trends in Pharmacological Sciences, 1995
- Neuropharmacology of 5-hydroxytryptamine1B/D receptor ligandsPharmacology & Therapeutics, 1994
- 5-HT1C/5-HT2 receptor blockade prevents 1-(2,5-dimethoxy-4-iodophenyl)2-aminopropane-, but not stress-induced increases in brain tryptophanEuropean Journal of Pharmacology, 1993
- The effect of adrenergic drugs on serotonin metabolism in the nucleus raphe dorsalis of the rat, studied by in vivo voltammetryEuropean Journal of Pharmacology, 1992
- The 5-HT2 receptor agonist 1-(2,5-dimethoxy-4-iodophenyl) 2-aminopropane increases brain tryptophan levels in the ratEuropean Journal of Pharmacology, 1992
- TFMPP and RU24969 enhance serotonin release rat hipocampusEuropean Journal of Pharmacology, 1990
- Suppression of firing activity of 5-HT neurons in the dorsal raphe by alpha-adrenoceptor antagonistsNeuropharmacology, 1980